Introduction
In 1997, PTEN (phosphatase and tensin homologue deleted on chromosome 10) was identified as the gene of interest in a region of chromosome 10 (10q23.3) that was known to be frequently deleted in high-grade tumors of the prostate and brain (Li et al., 1997; Steck et al., 1997) . Shortly thereafter, Maehama and Dixon (1998) biochemically characterized Pten as a phosphatase preferentially dephosphorylating the second-messenger molecule phosphatidylinositol-3,4,5-trisphosphate. Stambolic et al. (1998) showed that Pten negatively regulates phosphorylation of the important cell survival kinase Akt. The next few years witnessed an explosion of studies on the function of Pten as a tumor suppressor, with the identification of its upstream and downstream signaling elements, determination of its subcellular localization and characterization of its regulation by transcriptional and post-translational controls. In human cancers, there has been extensive verification that PTEN is mutated or otherwise inactivated in a large proportion of them, particularly in those that are aggressive and prognostically unfavorable. It has also become clear that germline PTEN mutations in humans can result in different disease syndromes. These include Cowden disease and Bannayan-Riley-Ruvalcaba syndrome, which are characterized by multiple hamartomatous lesions of different organs, including the skin, central nervous system, small and large intestines, eyes and bone, and which predispose to certain cancers, especially those of the thyroid, breast and endometrium. Another interesting syndrome caused by PTEN germline mutations is Lhermitte-Duclos syndrome, which presents as a benign, although growing, hamartomatous mass lesion of the cerebellum, resulting in cerebellar symptoms and possibly internal hydrocephalus. Intriguingly, PTEN is also genetically altered in a fraction of patients with autism spectrum disorders (Butler et al., 2005) . All these in vitro and in vivo studies point to the importance of Pten for normal development and physiology as well as tumor suppression. In this review, we will focus on mouse models, especially those using a conditional genetargeting approach, that have been useful in characterizing the developmental, physiological and tumor suppressive properties of Pten in various tissues and organ systems.
Central nervous system
The brain is one of the most extensively studied organs in the field of Pten research because PTEN is frequently mutated in glioblastomas, the most aggressive primary brain tumor in humans (Knobbe et al., 2002) . There are a number of different brain phenotypes and syndromes associated with germline PTEN mutations. In Lhermitte-Duclos disease, patients develop dysplastic gangliocytoma, a benign cerebellar mass. Histologically, this mass is composed of large neuronal cells that expand the granular and molecular layer of the cerebellar cortex. In Cowden disease, patients exhibit megaloencephaly in 20-70% cases, as well as gray matter heterotopias, mental retardation, autism, seizures and/or hydrocephalus (Wiestler et al., 2000; Butler et al., 2005; Herman et al., 2007) .
The first three papers on conditional Pten deletion in murine brain were published by Backman et al. (2001) , Groszer et al. (2001) and Kwon et al. (2001) . In both Backman and Kwon studies, mice with a conditional null mutation of the Pten gene (Pten flox/flox mice) were crossed to transgenic mice in which Cre recombinase expression was driven by the glial fibrillary acidic protein (Gfap) promoter. Two different GfapCrePten flox/flox strains were generated that had very similar phenotypes. Both strains of mutant mice developed seizures and ataxia early in life and died prematurely. Backman et al. found that seizure onset occurred at around 9 weeks of age and the mice died before 29 weeks. Kwon et al. observed that seizures started at about 6 weeks and the mice died before 48 weeks. In both cases, Pten was inactivated mainly in the granule cells of the cerebellum but also to a limited extent in the granule cells of the dentate gyrus in the hippocampus. Both groups also reported that the size of the brains of GfapCrePten flox/flox mice increased progressively over time, when compared with the brains of wildtype littermates, and that the mutants often developed internal hydrocephalus with expansion of the lateral ventricles. Histologically, the cerebellar cortex exhibited pronounced dysplasia, with some granule cells being abnormally located in the external granule cell layer. A thickened internal granule cell layer and dysplastic Purkinje cells were also noted. Lastly, the mutants showed a progressive increase in neuronal soma size, with Pten-deficient neurons being about twice the size of wild-type neurons. In both studies, the phenotypes of the GfapCrePten flox/flox mutants recapitulated many aspects of the phenotypes associated with PTEN germline mutations in humans.
Subsequent studies by Baker et al. showed that the cellular hypertrophy observed in GfapCrePten flox/flox mice was dependent on mTor but not on S6k1 activity (Kwon et al., 2003; Chalhoub et al., 2006) . Furthermore, the hypertrophic neurons of the mutants displayed increased ribosome density as well as enlarged nucleoli. These latter findings are in line with the observed increase in mTor activity in these animals upon inactivation of Pten. Increases in dendritic spine density as well as in the caliber of neuronal projections were also noted along with changes in synaptic structure, signal transmission and plasticity. In oligodendrocytes, Pten appeared to be important for the proper myelination of axons. Astrocytes from GfapCrePten flox/flox mice demonstrated greater in vivo and in vitro proliferation compared with control astrocytes, but no tumor formation was observed (Fraser et al., 2004) .
To further characterize the function of Pten in terminally differentiated neurons, Kwon et al. (2006) generated transgenic mice expressing Cre under the control of the Nse (neuron-specific enolase) promoter. In these animals, Cre activity occurs only in post-mitotic neurons of layers III-V of the cerebral cortex, as well as in the granular and polymorphic layers of the dentate gyrus. Deletion of Pten using NseCre mice resulted in soma hypertrophy, macroencephaly and premature death. In addition, NseCrePten flox/flox mice exhibited increased axonal outgrowth as well as altered spine morphology. In contrast to GfapCrePten flox/flox mice, these changes were observed mainly in the forebrain and hippocampus. Behaviorally, NseCrePten flox/flox mice displayed abnormal social interaction, increased anxiety, hyperactivity and increased sensory sensitivity. To some extent, the morphological and behavioral phenotypes of these mutants resembled those of patients with autism spectrum disorders (Kwon et al., 2006) . Subsequent analyses of these animals showed that they also exhibited sporadic spontaneous seizures (Ogawa et al., 2007) .
A third study of GfapCre-induced Pten deficiency was carried out by Yue et al. (2005) . These investigators observed neuronal migratory defects that were similar to those described by Backman et al. and Kwon et al. and resulted in an abnormal accumulation of granule cells in the external granule cell layer. In further analyses of this migratory defect, Yue et al. (2005) found that the Bergmann-glia connections that reach up through the subpial layers onto the pial surface were missing in the absence of Pten. The external granule cells were thereby unable to migrate along the Bergmann-glia connections into the internal granule cell layer, leading to an accumulation of subpial granule cells, which partially accounted for the disorganized cerebellar architecture. Groszer et al. (2001) crossed mice expressing Cre under the control of the nestin promoter (NesCre) to conditional Pten mice. These mice showed a continuous increase in brain size throughout embryonic development such that their brains were twice the size of control brains at day P0. In addition, individual cells from the mutant brain were larger than those from wild-type brains. The mutant mice died soon after birth and histological examination revealed severe disturbances of gross as well as patterning throughout the brain. After analysing the proliferation pattern of cells in the developing mutant brain, Groszer et al. (2006) concluded that Pten most likely controls neural stem/ progenitor cells by negatively regulating their cell cycle progression. Neurosphere assays subsequently demonstrated that Pten-deficient neural stem cells underwent more self-renewing divisions than did their wild-type counterparts, and also showed decreased growth factor dependency.
Two additional mutant mice with brain-specific Pten deficiency were generated by Marino et al. (2002) . One transgenic mouse strain expressed Cre under the control of the engrailed-2 promoter (En2Cre). Crossing of this strain to Pten flox/flox mice resulted in the inactivation of Pten in cells that localize to the dorsal midbrainhindbrain junction at around day E9.5 and give rise to cells that eventually populate the vermis of the cerebellum. The other transgenic mouse strain expressed Cre under the control of the L7 promoter, which resulted in the selective inactivation of Pten in Purkinje cells. Studies of the En2CrePten flox/flox mice showed that the loss of Pten interfered neither with the ability of the precursors of the dorsal midbrain-hindbrain junction to differentiate into the different cell types composing the vermis, nor to a major extent with the migration of these cells to the vermis. The mutant cells, however, did not proliferate as well as their wild-type counterparts, and the mutant mice demonstrated a progressive loss of Purkinje cells, which started in early postnatal development and was characterized by increasing vacuolation of the cells concurrent with the accumulation of fibrillary inclusions. On the other hand, the mice also showed an increase in cerebellar size, neurons with greater soma size and thickened dendrites, dysplastic astrocytes and abnormally localized oligodendrocytes. Studies of the L7CrePten flox/flox mice demonstrated that the Purkinje cells again showed vacuolation and cell loss as well as accumulation of a fibrillary material, but the other features observed in the En2CrePten flox/flox mice were absent (Marino et al., 2002) .
We note here that mice with a selective deletion of Pten in proopiomelanocortin (Pomc)-producing neurons have been generated, but we have chosen to discuss them below in the context of metabolic changes in mice with targeted deletions of Pten.
Taken together, the studies outlined above indicate that the deletion of Pten at various time points during the development of the central nervous system results in different phenotypes with early deletion (NesCre), resulting in hyperproliferation and hypertrophy together with aberrations of normal development and alterations to cell fate, and, afterward, deletion in hypertrophy with or without migratory defects of certain neuronal as well as glial populations. Although PTEN is frequently inactivated in malignant human brain tumors, inactivation of Pten in the mouse brain does not lead to tumor development, which may be due to the fact that additional genetic alterations are necessary (Wei et al., 2006) .
Reproductive and urogenital systems
Breast Patients with Cowden disease show an increased risk of developing breast and endometrial cancers. Thus, it was interesting that mice heterozygous for a null mutation of Pten (Pten þ /À mice) also showed a higher risk for the development of these tumors (Stambolic et al., 2000) . By 30-49 weeks of age, 61% female Pten þ /À mice had developed mammary tumors that were mainly adenocarcinomas or small fibroadenomas. This incidence had increased to 83% by age 50-66 weeks. Although rare, metastases to the lymph nodes and lung were seen in 6% of female Pten þ /À mice (Stambolic et al., 2000) . Li et al., 2001 crossed Pten þ /À mice with mice overexpressing Wnt under the control of the mouse mammary tumor virus promoter (MMTV-Wnt) and observed that breast tumors developed earlier than in either Pten þ /À or MMTV-Wnt mice. Generation of mice with conditional inactivation of Pten in the mammary epithelium using two different MMTVCre mouse strains resulted in developmental defects of the mammary gland. Mammary ducts in the mutant mice grew much faster than in wild-type mice and exhibited excessive side branching and precocious lobuloalveolar budding. These developmental changes were seen during puberty as well as during pregnancy. Defects in mammary gland involution after pregnancy were also observed. In addition, tumor development in MMTVCrePten flox/flox mice occurred as early as at 2 months of age, with the tumors varying histologically from benign fibroadenomas to pleiomorphic adenocarcinomas. Interestingly, the authors noted that the mammary epithelial cells in these mutants showed increased staining for cytokeratins 5 and 6 (Li et al., 2002) . In human breast tumors, expression of these two cytokeratins is one of the major markers for the identification of tumors of the basal subtype (Sorlie et al., 2001) . The basal subtype often occurs in patients with germline BRCA1 mutations and is associated with a poor prognosis. A recent study by Saal et al. (2008) has shown that breast tumors from Pten þ /À mice tend to show similarities with human breast cancers of the basal subtype.
Endometrium PTEN mutations are seen in the majority of human endometrial cancers, particularly in those arising in the context of endometrial hyperplasia. Podsypanina et al. (1999) showed that all female Pten þ /À mice developed multifocal endometrial complex atypical hyperplasia between the ages of 18 and 39 weeks. In humans, this type of lesion is thought to be a precursor lesion to endometrial carcinoma. The results obtained by Podsypanina et al. were later confirmed by Stambolic et al. (2000) , who found that all female Pten þ /À mice aged >26 weeks developed endometrial hyperplasia. Of these hyperplasias, 20% were simple in type, whereas the remaining 80% showed various degrees of atypia, with higher grades of atypia commonly occurring in older mice.
The data acquired from these studies of Pten-deficient mice are in line with observations of human tumor samples, in that genetic deficiency of PTEN tends to give rise to endometrial hyperplasia with or without atypia. However, the acquisition of mutations to genes in addition to PTEN appears to be necessary for the progression of these hyperplasias to invasive carcinomas.
Bladder PTEN loss-of-heterozygosity or point mutations of the PTEN gene have been observed in only 5-6% of human primary bladder cancers (Aveyard et al., 1999; Liu et al., 2000; Wang et al., 2000) . To examine the function of Pten in murine bladder, Tsuruta et al. (2006) and Yoo et al. (2006) used FabpCre transgenic mice to preferentially delete Pten in the urothelium of the bladder, kidney and ureter. Notably, Pten deletion also occurred in the colon, prostate, seminal vesicles and vagina of these mutants (Yoo et al., 2006) . Further analyses by both groups focused on the urothelial epithelium. Urothelial hyperplasia reached 100% penetrance at either 6 (Yoo et al., 2006) or 8 weeks (Tsuruta et al., 2006) of age. Yoo et al. (2006) reported that by 54 weeks, spontaneous urothelial carcinomas had developed at frequencies of 22, 12 and 48% in the bladder, ureter and kidneys, respectively (Yoo et al., 2006) . In contrast, Tsuruta et al. observed only a 10% incidence of urothelial carcinomas in 40-to 80-week-old mice. Tsuruta et al. then went on to show that deletion of Pten in the urothelium resulted in increased susceptibility to chemically induced carcinogenesis. They treated their mutant mice with oral N-butyl-N-(4-hydroxybutyl) nitrosamine, which is known to induce urothelial carcinomas of the bladder, and found that tumor formation was increased in the mutant animals, when compared with the wild-type animals (Tsuruta et al., 2006) . Moreover, they found that Pten protein expression is frequently reduced in human bladder patients (Tsuruta et al., 2006) .
Thus, deletion of Pten in urothelial cells may result in predisposition to urothelial hyperplasia and development of bladder cancer.
Prostate PTEN loss-of-heterozygosity and mutations in the PTEN gene are frequently observed in human prostate cancers, especially in higher grade tumors and metastases. Indeed, it was the deletion of the chromosomal region containing PTEN in prostate cancer cell lines as well as in glioblastoma cell lines that led to the identification of PTEN as a tumor suppressor gene (Li et al., 1997; Deocampo et al., 2003) . Murine prostate cancer, like human prostate cancer, undergoes disease progression. Epithelial hyperplasia is followed by low-and high-grade prostatic intraepithelial neoplasia (PIN), and finally by invasion of the cancer cells through the basement membrane into the surrounding stroma to establish invasive adenocarcinomas (DeMarzo et al., 2003; Marandola et al., 2004) . Podsypanina et al. (1999) and Stambolic et al. (2000) examined the prostates of Pten þ /À mice and noted the changes in the prostate epithelium, including benign epithelial hyperplasia and intraepithelial neoplasia, as well as rare instances of adenocarcinoma.
To investigate the dose effect of Pten in the development of prostate cancer, Trotman et al. (2003) Mice with complete loss of Pten in the prostate showed 100% penetrance of invasive prostate cancer starting at the age of 6 months. In contrast, the penetrance of such tumors in Pten hyp/À mice was only 25%. These data indicate that the presence of even a low amount of Pten is sufficient to protect against prostate tumorigenesis (Trotman et al., 2003) . Wang et al. (2003) also used PbCre4 transgenic mice to generate mutants with a conditional deletion of Pten in prostate epithelium. By 4 weeks of age, all PbCre4Pten flox/flox mice showed prostatic hyperplasia, which progressed to PIN at 6 weeks and to invasive adenocarcinoma at 9-29 weeks. In a fraction of these mice, metastases developed after 12-29 weeks. Backman et al. (2004) used the MMTVCre mice to conditionally delete Pten in the prostate. Male MMTVCrePten flox/flox mice showed very early onset of pathological changes in the prostate, with 6 out of 9 mice examined displaying epithelial hyperplasia at 5 days of age. High-grade PIN and prostate carcinoma in situ (PCIS) were observed in all mutant males by the age of 2 weeks. Invasive adenocarcinomas were first seen at 3 weeks and had developed in more than half of the mutants by 7-14 weeks. These data show that, if Pten has already been deleted in the prostate during development, the incidence, penetrance and progression of neoplasia are much greater than if Pten is lost during or after puberty.
Another strain of mice with a prostate-specific deletion of Pten was created by Ma et al. (2005) using Cre under the control of the PSA (prostate-specific antigen) promoter. At the age of 4-5 months, all mutant mice showed prostate hyperplasia with focal PIN. By 7-9 months, PIN was widespread and focal microinvasion was observed. All mutant mice aged 10-14 months showed invasive prostate cancer. Interestingly, the tumor cells of these animals retained androgen receptor expression. Building on the work of Ma et al., Ratnacaram et al. (2008) generated mice with an inducible conditional mutation of Pten in prostate epithelium by crossing Pten flox/flox mice with PSACreER(T2) transgenic mice. PSACreER(T2) mice express tamoxifen-inducible Cre under the control of the PSA promoter. After ablation of Pten by tamoxifen application, the mutant mice developed prostate hyperplasia within 4 weeks and PIN in all lobes within 2-3 months. By 10 months, PIN had progressed to adenocarcinoma in some mice; however, no metastases were observed.
The sum of the results from these various mouse models is that deletion of Pten in prostate epithelial cells results in early neoplastic changes that can ultimately lead to the development of invasive and possibly metastatic adenocarcinomas. the growth differentiation factor 9 promoter (Gdf9Cre). Normal oocytes are successively activated over a long period of time, ensuring that the mammalian female can reproduce through an extended period of her adult life. In contrast, Pten deficiency in murine oocytes caused the entire oocyte pool to become activated early in life. This premature oocyte activation resulted in females having a maximum of one normal-sized litter before they became infertile at 12-13 weeks of age. Thus, Pten is important for the normal physiology of oocytes.
Primordial germ cells
Primordial germ cells (PGCs) are germ cell precursors that migrate along the genital ridges to become oocytes or sperm. In mice, PGCs are detectable starting at embryonic day E7.5. Kimura et al. (2003) selectively deleted Pten in PGCs giving rise to sperm cells by crossing Pten flox/flox females with Pten þ /À males that carried a single TNAP/Cre locus in which Cre was knocked into the PGC-specific TNAP gene. All newborn male mice with deletion of Pten in PGCs showed testicular teratomas. In vitro culture of PGCs showed that PGCs had greater proliferative activity and enhanced pluripotent embryonic germ-cell colony formation. These data emphasize that Pten is important for multiple aspects of normal reproductive physiology and for protection from the development of germ-cell tumors.
Immune system
Analyses of Pten þ /À mice as well as conditional inactivation of Pten in different cell populations of the immune system, including T cells, B cells, myeloid cells, NKT cells and hematopoietic stem cells (HSCs), showed that depending on the cell type, Pten may be important for proper development, cell fate and cell function, as well as for protection from tumorigenesis.
T-cells
The dominant phenotype observed in Pten þ /À mice was lymphoid hyperplasia that progressed to T-cell lymphoma Podsypanina et al., 1999) . The initial lymphoid hyperplasia in these animals first appeared at 20 weeks of age and took the form of large nodal masses in the neck and axilla (Podsypanina et al., 1999) . All female Pten þ /À mice and 45% of male Pten þ /À mice older than 50 weeks of age displayed such lesions. On detailed examination, these lesions proved to be enlarged lymph nodes that showed expansion of the interfollicular areas and medullary cords, as well as residual follicular and paracortical hyperplasia composed of B and T cells, macrophages and fibroblasts (Podsypanina et al., 1999) . Lymph node architecture was also modified, in that the B-and T-cell zones were mixed. Annexin V staining showed that B cells and macrophages of Pten þ /À mice had reduced levels of apoptosis compared with wild-type cells. Interestingly, Pten þ /À T cells did not show reduced apoptosis, and the histological morphology and size of the Pten þ /À thymus were not altered (Podsypanina et al., 1999) .
Di Cristofano et al. (1999) also characterized the immune system in a strain of Pten þ /À mice and observed that these mutants developed a lethal polyclonal autoimmune disorder. By 16-20 weeks of age, 98% Pten þ /À females showed severe lymphadenopathy, and by week 32, 83% Pten þ /À males had developed mild lymph node hyperplasia. Normal proportions of T and B cells were present in the lymph nodes and lymphocyte expansion was polyclonal. Fas-mediated apoptosis of activated Pten þ /À T cells was impaired, and Pten
T cells showed increased proliferation after activation. In addition, these mice developed autoimmune glomerulopathy as well as abnormal thickening of the interstitial alveolar spaces of the lung. The Pten þ /À mice of Stambolic et al. (2000) developed hyperplasia of the lymphoid organs that disrupted the corticomedullary architecture. A mixed inflammatory cell infiltrate was present, which included atypical lymphocytes. About 20% of these Pten þ /À mice developed malignant lymphomas in which monomorphous infiltrates invaded solid organs, such as the kidney, lung and liver. Lymphoma occurred in Pten þ /À mice of all ages and at similar frequencies in both sexes.
To elucidate why Pten þ /À mice develop mainly T-cell lymphomas, several groups have selectively deleted Pten in T cells using Cre under the control of T-cell-specific promoters. Suzuki et al. (2001) found that LckCrePten flox/À mice, in which Pten is deleted in all T lineage cells, showed lymphadenopathy, splenomegaly and an enlarged thymus at 6-8 weeks of age. Tumor formation was observed from 10 weeks onward, and all 16 mice analysed died of malignant T-cell lymphoma by week 17. LckPten flox/À mice also showed signs of autoreactivity, including impaired negative thymic selection, increased levels of autoantibodies, enhanced T-cell proliferation and elevated cytokine production. Apoptosis of isolated LckPten flox/À T cells was decreased. Hagenbeek et al. (2004) generated LckCrePten flox/flox mice and reported that all 20 mutant animals examined also died of T-cell lymphomas by the age of 17 weeks. However, in contrast to the findings of Suzuki et al., Hagenbeek et al. did not observe significant increases in thymic cellularity before the onset of lymphoma. They also did not detect any major differences between mutant and wild-type mice in the distribution of various CD4 þ , CD8 þ , double negative (DN) and double positive (DP) T-cell subsets. Hagenbeek and Spits (2008) went on to analyse CD4CrePten flox/flox mice in comparison with LckCrePten flox/flox mice and concluded that the infiltrating T-cell lymphomas developing in both mutants originated in the thymus. Xue et al. (2008) also studied tumorigenesis in LckCre Pten flox/flox mice. Their work indicated that, although CD4 þ CD8 À T-cell lymphomas appeared at approximately 10 weeks of age and the mutant mice died by 15 weeks, a DP T-cell premalignancy was evident in the mutant thymus at around 9 weeks. As the Lck promoter becomes active from E17 onward, deletion of Pten in LckCrePten flox/flox mice should be induced at around this time. Intracellular staining for Pten of DP thymocytes of 3-week-old LckCrePten flox/flox mice showed loss of Pten expression in almost 100% cells. Interestingly, however, hyperphosphorylation of Akt and Foxo3a was only observed in DP thymocytes from mice 6 weeks of age or older. The latter finding and the delay in the appearance of lymphoma in the mutants generated by Xue et al. (2008) suggest that tumor-driving events in addition to loss of Pten most likely are dependent on developmental, for example, hormonal changes occurring at around 6 weeks of age, most likely related to puberty. This also appears to be most probable as DP thymocytes live for only 3-4 days, which would be too short for secondary hits to occur in a significant number of cells. Interestingly, repeated application of dexamethasone to LckCrePten flox/flox mice at ages 7.5, 8.5 and 9.5 weeks resulted in a transient reduction in DP thymocytes and a 3-to 4-week delay in mouse lethality. The implication is that a reduction in DP thymocytes slowed tumorigenesis.
Despite some discrepancies, these collective data indicate that loss of Pten in T cells leads to the development of malignant T-cell lymphomas with high penetrance.
B-cells
By crossing CD19Cre transgenic mice with Pten flox/flox mice, Suzuki et al. (2003b) deleted Pten specifically in the B-cell lineage. Surprisingly, the mutant animals did not develop B-cell malignancies. Cell numbers in the bone marrow were normal, as were the numbers of pro-and pre-B cells. However, the total numbers of splenocytes, mesenteric lymph node cells and peritoneal cells were increased. In the peritoneal cavity and the spleen, the increase in cell numbers was attributed to an increase in B1a cells. In the spleen, there were also alterations of B2 B cells, with an increase in marginal zone B cells and a decrease in follicular B cells (in both relative and absolute terms). The Pten-deficient B2 B cells showed enhanced proliferation on stimulation as well as reduced apoptosis after IgM stimulation. Furthermore, the mutant mice displayed changes in their serum immunoglobulin (Ig) profiles, showing decreased levels of IgA and most IgG subclasses but elevated levels of IgM. These alterations in Ig levels were because of defective class switch recombination, which in turn was most likely due to significantly reduced mRNA levels of activation-induced cytidine deaminase. The authors concluded that Pten expression in B cells was indispensable for proper B-cell development, numbers and functions.
Anzelon et al. also used a strain of CD19Cre transgenic mice to selectively delete Pten in B cells. Like Suzuki et al., these investigators observed that Pten deletion in B cells led to the preferential generation of marginal zone B cells. Pten-deficient B cells were hyperproliferative in response to mitogenic stimuli.
Overall, these data show that Pten is important for Bcell physiology, including B-cell maturation and proliferation following antigen stimulation. The lack of tumor development in the mutant mice may be due to the fact that class switch recombination is defective in Pten-deficient B cells due to decreased levels of activation-induced cytidine deaminase, which, on the other hand, appears to be essential for germinal center B-cell lymphomagenesis (Pasqualucci et al., 2008) .
NKT cells
Va14iNKT cells play an important role in a number of innate and adaptive immune responses, including those combating microbial infections as well as those protecting from tumor metastasis. Mice lacking these cells have been shown to display impaired tumor rejection. Therefore, Kishimoto et al. (2007) Va14iNKT cells were adoptively transferred into Ja À/À mice that had been inoculated with highly metastatic B16F10 melanoma cells, heterozygous and homozygous Pten deficiency of the Va14iNKT cells resulted in strongly decreased protection from metastases, when compared with the protection from metastases conferred by transferred wild-type Va14iNKT cells. Thus, Pten is important for both development and function of Va14iNKT cells. These data indicate that Pten is important for normal development of Va14iNKT cells, and Cowden disease patients may not only be at risk of developing tumors, but may also experience rapid growth of these tumors due to the impairment of immunesurveillance by NKT cells.
Granulocytes
To investigate the function of Pten in murine neutrophils, Subramanian et al. used mice in which Cre was integrated into the endogenous lysozyme M gene to generate a strain in which Pten was deleted in myeloid lineage cells. The neutrophils in these mutants displayed high levels of phosphatidylinositol-3,4,5-trisphosphate, increased actin polymerization and enhanced membrane ruffling. Furthermore, the Ptendeficient neutrophils showed increases in superoxide production, pseudopodia formation, transwell chemotaxis and migratory speed. Although the migration of the mutant cells was less directional than that of wildtype cells, there was no significant deficit in chemotaxis.
Roles of PTEN: a tissue-by-tissue survey CB Knobbe et al No significant deficit in neutrophil chemotaxis was also confirmed by Nishio et al. (2007) . Indeed, in an in vivo inflammation/peritonitis model, Pten inactivation in neutrophils resulted in a striking increase of neutrophil recruitment upon intraperitoneal Escherichia coli infection. These results indicate that Pten inactivation in the myeloid lineage does not affect neutrophil maturation but does enhance neutrophil functions.
Macrophages
Using the same Cre transgenic mouse strain as Zhu et al. to characterize the effect of deletion of Pten in granulocytes (LysMCre), Kuroda et al. (2008) studied the effect of deletion of Pten in macrophages. They found that LysMCrePten flox/flox mice were more susceptible to infection with Leishmania and showed a slower clearance of infection than their wild-type littermates. This lack of resistance to infection was most likely due to decreased secretion of tumor necrosis factor by the mutant macrophages, which in turn correlated with reduced expression of inducible nitric oxide synthase and a consecutive reduction in nitric oxide production (Kuroda et al., 2008) .
Hematopoietic stem cells
Deletion of Pten in murine HSCs has been studied by two groups, both of which used transgenic mice expressing Cre under the control of the polyinosine-polycytidine (pIpC) inducible Mx1 promoter (Yilmaz et al., 2006) . Yilmaz et al. administered pIpC for 14 days to 6-to 8-week-old mice, whereas Zhang et al. administered pIpC on days P21, P23 and P25. Both groups observed the rapid onset of myeloproliferative disorders within 30 days (Zhang et al.) or 4-6 weeks (Yilmaz et al.) after pIpC administration. These myeloproliferative disorders rapidly progressed to acute myeloid leukemia or acute lymphoblastic leukemia. Both groups also showed that Pten-deficient HSCs could not remain quiescent and that this resulted in rapid depletion of the HSC pool. When the Pten-deficient HSCs were transplanted into irradiated recipient mice, the recipients became increasingly incapable of producing sufficient hematopoietic cells of all lineages. Interestingly, the phenotypes of increased HSC proliferation, development of myeloproliferative disorders and leukemia could all be rescued if the mutant mice were treated with rapamycin for 7 days after pIpC administration (Yilmaz et al., 2006) . The treated mice did not show HSC failure, and transplanted HSCs from these mice did not induce HSC failure in recipients. Furthermore, rapamycin was effective in prolonging the life span of mice even if it was administered after the appearance of leukemic cells. Yilmaz et al. (2006) reason that the lack of Pten may have increased phosphoinositide 3-kinase (PI3K) signaling in HSCs, and thus may have accelerated senescence through p53 activation, resulting in HSC pool depletion. Furthermore, during leukemogenesis, this induction of senescence may have been overcome by the acquisition of additional genetic alterations (for example, p53 mutation).
These results show that similar to the observations for oocytes (see above), Pten protects HSCs against premature cell cycle re-entry. The murine keratin 5 promoter is active in the basal layer of epidermal and follicular keratinocytes from day E13.5 onward. K5Cre-driven deletion of Pten induced hyperplasia of both skin and esophageal squamous epithelium (Suzuki et al., 2003a) . The skin hyperplasia caused affected pups to appear wrinkled by 3 days after birth and to show abnormally ruffled and shaggy hair by 6 days. The esophageal hyperplasia resulted in malnutrition in pups during lactation, such that approximately 90% of them died within 21 days of birth. Closer analysis of skin morphogenesis revealed precocious skin development. Although it is thought that the timeline of skin development is regulated by the Wnt/b-catenin/ LCF-1 pathway, no clear differences between k5CrePten þ / þ and k5CrePten flox/flox mice were observed in the nuclear and cytoplasmic distribution of b-catenin. Long-term (8.5 months) observation of surviving k5CrePten flox/flox mice demonstrated that all the mutants eventually developed skin tumors, such as papillomas and/or squamous cell carcinomas. Furthermore, 23% of k5CrePten flox/ þ mice developed papillomas and/or squamous cell carcinomas during the same observation period.
MMTVCre-dependent inactivation of Pten in the skin induced macroscopically hyperplastic changes of the skin by day P7 (Backman et al., 2004) . Furthermore, the coat of MMTVCrePten flox/flox mice became shaggy and ruffled by day P21. The palmoplantar regions of the paws of these mutants showed hyperkeratosis and hypergranulosis that were similar to the benign tumors that develop on the hands and feet of Cowden disease patients. In addition, sebaceous glands were more abundant in the mutant mice. As MMTVCre is also active in the thymus, the mice in this study developed thymic lymphoma by the age of 3 months, precluding any analysis of skin tumors. Yang et al. (2005) used k5Cre mice to create a conditional mutant with a combined deletion of Smad4 and Pten. These double mutants showed earlier skin tumor onset than the k5CrePten flox/flox mice. In addition, k5CreSmad4 flox/flox mice presented with progressive hair loss and 70% penetrance of skin tumor formation within 12 months (starting at B5 months of age), whereas the double-mutant mice developed skin tumors at B2 months of age, unless they succumbed to forestomach cancers which occurred at high penetrance (Yang et al., 2005; Teng et al., 2006) . These results suggest a synergistic interaction between Smad4 and Pten mutations in skin tumorigenesis. (You et al., 2002) . Recently Inoue-Narita et al. (2008) generated mice with conditional inactivation of Pten in cells expressing dopachrome tautomerase (Dct, also called tyrosinase-related protein 2). Dct is expressed in pigment-producing cells, including melanocytes, melanocyte stem cells and retinal pigment epithelial cells as well as in cells in several brain regions, including the dentate gyrus of the hippocampus and the cortex. Half of the mutant mice died shortly after birth due to enlargement of the cortex and the hippocampus. The surviving mice displayed increased numbers of melanocytes in the skin, and melanocyte stem cells were resistant to exhaustion after repeated depilations, as shown by the protection from hair graying. With respect to melanoma pathogenesis, the authors did not observe any increases in spontaneous tumor development. However, upon chemical carcinogenesis treatment, mutant mice showed a significant increase in the development of melanocytic lesions, including the formation of large nevi, as well as of invasive spindle cell melanomas, compared with wild-type mice.
In summary, Pten plays an important role for protection from both epithelial as well as melanocytic tumor formation in the skin. In addition, it regulates the timing of proper skin development in the squamous epithelium and protects melanocytic stem cells from exhaustion.
Gastrointestinal tract
The gastrointestinal (GI) tract can also be involved in Cowden disease, as patients sometimes present with GI polyps as well as colorectal and gastric carcinomas. However, studies of sporadic cancers of the human GI tract have indicated that PTEN inactivation is not one of the dominant early mechanisms of GI tumorigenesis. Indeed, colorectal carcinomas rarely feature mutations or deletions of PTEN, or loss of Pten mRNA or protein expression (Taniyama et al., 2001) .
In line with the phenotype of germline PTEN mutations in humans, Pten þ /À mice develop hamartomatous polyps in the colon (Di Cristofano et al., 1998; Suzuki et al., 1998) . Shao et al. (2007) crossed Pten þ /À mice to APC À/ þ mice (which develop colorectal adenomas) and showed that constitutive loss of one Pten allele in combination with one APC À allele was sufficient to induce the formation of invasive colorectal carcinomas. Lu et al. (2007) used a different approach to show that deletion of Pten can induce GI tumorigenesis. They bred floxed Pten mice (Pten flox/flox or Pten flox/ þ ) to mice expressing tamoxifen-sensitive Cre recombinase under the Rosa26 promoter (R26CreER) and inactivated Pten at the age of 45 weeks by administration of tamoxifen for 10 days. Both male and female mutants developed tumors in multiple organs after a short latency period. Interestingly, the development of intestinal tumors was observed only in male mice.
The presented results suggest that inactivation of Pten alone is a relatively weak initiator of GI tumorigenesis, but that deletion of Pten in combination with deletion of another tumor suppressor (for example, APC) may be more potent. It remains to be determined whether the cooperation of Pten with other tumor suppressors (such as APC) is important for preventing the development of cancer in the human GI tract.
In another model, He et al. (2007) could show that inducible inactivation of Pten in intestinal stem cells (ISCs) using Mx1CrePten flox/flox mice resulted in hamartomatous intestinal polyps with epithelial and stromal involvement resembling intestinal polyposis, a condition with abnormally increased numbers of crypts. The authors demonstrated that these Pten-deficient ISCs were hyperproliferative and initiated de novo crypt formation and crypt fission. In addition the authors could show that these changes were associated with increases in nuclear b-catenin staining which they attributed to the increased phosphorylation of b-catenin by Akt.
Lung
Although patients with Cowden disease do not have a known increase in the risk of developing lung cancer, Pten expression is often dysregulated in human lung adenocarcinomas (Marsit et al., 2005; Tang et al., 2006) . To analyse the importance of Pten in murine lung development and lung tumorigenesis, Yanagi et al. (2007) conditionally deleted Pten in lung tissue using a doxycycline-inducible expression system under the control of the SP-C promoter (surfactant, pulmonary associated protein C). Induced deletion of Pten during embryogenesis (days E10-E16) resulted in impaired lung morphogenesis leading to early postnatal death due to hypoxia in about 90% pups. Histologically, the lungs of these pups showed increased numbers of epithelial cells and impaired alveolar cell differentiation. Lung-specific deletion of Pten in mice after birth (P21-P27 or P84-P90) resulted in bronchiolar and alveolar epithelial hyperplasia. In addition, these mutant mice showed slight increases in the cell sizes of both AE-I and AE-II (alveolar type I and alveolar type II) cells, which are derived from bronchioalveolar stem cells. Long-term monitoring revealed that lung tumors developed in all surviving mice in which Pten was deleted during embryogenesis, and in 87% of mice in which Pten was deleted postnatally (P21-P27). These results show that Pten is important for both proper lung development and protection against lung tumorigenesis.
Endocrine system and metabolism

Thyroid gland
Cowden disease patients show changes within the thyroid, including adenomas, goiters and thyroid Roles of PTEN: a tissue-by-tissue survey CB Knobbe et al cancer. Abnormalities in this gland also occur in Ptendeficient mice. Podsypanina et al. (1999) reported that 3 out of 20 Pten þ /À mice showed follicular or papillary noninvasive neoplasias of the thyroid, and an additional 3 mice showed atypical epithelial changes. To further investigate the role of Pten inactivation in thyroid cancer development, Yeager et al. (2007) generated thyroid-specific Pten-deficient mice using TpoCre transgenic mice in which Cre is under the control of the thyroid peroxidase (Tpo) promoter. Diffuse goiters containing extremely enlarged follicles developed in these animals, whereas T4 hormone levels remained normal. Thyroid epithelial cell proliferation was higher in female mutant mice than in male, and by the age of 10 months, over two-thirds of the mutant females had developed thyroid adenomas. No invasive thyroid cancers were seen.
In summary, Pten deletion does not affect normal thyroid development and function, but may contribute to adenoma development. Stambolic et al. (2000) observed that one male and 18 females among 81 Pten þ /À mice showed proliferation and expansion of the adrenal medulla, which was consistent with hyperplasia or pheochromocytoma. The smaller lesions compressed the cortex of the adrenal gland, whereas the larger lesions penetrated the capsule of the adrenal gland and invaded the surrounding fat tissue. Invasive tumors appeared (usually unilaterally) in mice that were older than 35 weeks of age. Evidence supporting a role for Pten in protecting from the development of pheochromocytomas has also been obtained from the study of Ink4a You et al. (2002) . These mutant mice presented with a higher incidence of pheochromocytoma compared with Ink4a À/À or Pten þ /À mice, as well as a reduced latency of neoplasia. However, in humans, analyses of benign and malignant pheochromocytomas have indicated that PTEN inactivation plays only a minor role in the pathogenesis of these tumors (van Nederveen et al., 2006) . Liver PI3K pathway signaling is regulated, in part, by the insulin receptor and affects downstream proteins involved in metabolism (such as mTOR). Thus, loss of Pten not only increases tumor susceptibility but may alter metabolism as well. To explore Pten's function in the liver, two groups crossed Pten flox/flox mice with AlbCre mice, which express Cre under the control of the albumin (Alb) promoter (Horie et al., 2004; Stiles et al., 2004) . The phenotypes of the resulting mutant mice were very similar with respect to their morphological and metabolic aspects. However, only Horie et al. investigated liver tumorigenesis.
Adrenal glands
Both groups observed striking hepatomegaly in AlbCrePten flox/flox mice, which progressed with age. The ratio of liver weight to body weight was also increased in the mutants when compared with wild-type controls.
Furthermore, mutant livers became increasingly lighter in color with advancing age. Histologically, the mutant livers showed accumulation of cytoplasmic triglycerides that expanded over time to severe steatohepatitis (Horie et al., 2004; Stiles et al., 2004) . In addition, inflammatory cell infiltrates were observed in mutant livers at 24 weeks (Stiles et al., 2004) and 40 weeks (Horie et al., 2004) of age. Horie et al. (2004) noted that the phenotype of their liver-specific Pten-deficient mice resembled that of humans suffering from non-alcoholic steatohepatitis.
Fatty acids may be either taken up or synthesized by hepatocytes. Stiles et al. (2004) investigated whether Pten deficiency caused the mutant hepatocytes to increase their uptake or production of fatty acids. These investigators found that the passive diffusion of fatty acids into hepatocytes was increased in the absence of Pten, but active fatty acid uptake via fatty acid transporters was not affected. The net fatty acid uptake was therefore not significantly different from that in the wild-type mice. However, Pten-deficient hepatocytes showed a rate of fatty acid synthesis that was 2.5 times higher than that in controls (Horie et al., 2004) . Increased levels of liver fatty acid synthase were also observed (Stiles et al., 2004) . Horie et al. (2004) went on to explain the triglyceride accumulation and hepatic damage in the mutants by analysing the expression of several adipogenic and lipogenic genes. The activity of peroxisome proliferator-activated receptor-g, an activator of transcription during adipocyte differentiation, and the levels of its downstream targets were increased in Pten-deficient hepatocytes. There was also a moderate increase in SREBP-1c, another transcription factor regulating lipid synthesis, as well as in SREBP-1c targets.
With respect to glucose metabolism, both Stiles et al. (2004) and Horie et al. (2004) observed an increase in insulin sensitivity in liver-specific Pten-deficient mice, which resulted in lower fasting plasma glucose levels and reduced serum insulin levels. During intraperitoneal glucose tolerance testing, the clearance of glucose and the restoration of baseline values were accelerated in the absence of Pten. In addition to regulating glucose uptake by the liver, insulin regulates the synthesis of fatty acids and glycogen. Thus, steatohepatitis observed in liver-specific Pten-deficient mice may be due to insulin hypersensitivity. Stiles et al. further reported that the mutant mice generated by them displayed increased liver glycogen storage, and that the phosphorylation of glycogen synthase kinase-3b, a negative regulator of glycogen synthase, was increased by 50% in Ptendeficient hepatocytes. These data suggest that glycogen synthase activation is the cause of increased glycogen synthesis and storage observed in liver-specific Ptendeficient mice.
Analysis of the tumorigenicity of hepatic Pten deletion showed that 47% of the mutant mice had developed hepatic adenomas by 44 weeks of age, with 100% affected by 74-78 weeks (Horie et al., 2004) . Furthermore, 66% of 74-to 78-week-old mutant mice exhibited hepatocellular carcinomas. Of the 12 aged mice studied in detail, two exhibited lung metastases in addition to hepatocellular carcinomas.
Taken together, these studies show that Pten is critical for insulin regulation and liver homeostasis under physiological conditions, and also plays an important role in suppressing the development of hepatic adenomas and hepatocellular carcinomas, which, in these mice, occur at very high penetrance during aging.
Pancreas
The pancreas is composed of two different tissues that are distinguished both histologically and physiologically. The endocrine portion of the pancreas carries out insulin and glucagon production and secretion, whereas the exocrine portion produces enzymes that are secreted into the intestine for digestion. In humans, pancreatic cancers frequently show loss of Pten protein expression as well as AKT2 gene amplification (Stanger et al., 2005) .
To investigate the function of Pten in murine pancreatic islet b-cells, two groups independently generated conditional Pten-deficient mice using Cre driven by the rat insulin promoter (RipCre). Stiles et al. (2006) mainly focused on the effects of Pten deletion on b-cells, whereas Nguyen et al. (2006) also analysed the effect of the mutation on the hypothalamus, a region of the brain where the insulin gene is also transcribed, and thus where Cre is active in RipCre mice.
The RipCrePten flox/flox mice of Stiles et al. (2006) showed increases in islet cell numbers (1.5-fold) and total islet mass (area 4.5-fold and size 2-fold), which were evident as early as P15 and persisted until adulthood. This phenotype was explained by an increase in b-cell and possibly progenitor cell proliferation during late embryonic development (E17.5) and early postnatal life, followed by a twofold decrease in apoptosis during the pancreatic remodeling that occurs during postnatal weeks 2-3. Adult mutant mice were naturally hypoglycemic, and insulin tolerance tests were difficult to perform as the mutants frequently displayed severe hypoglycemia during fasting and had to be rescued by glucose injections. In general, islet function was retained in mutant mice with insulin secretion upon glucose stimulation. Unlike wild-type mice, mutant mice were resistant to streptozotocin-induced oxidative stress and diabetes development, as assessed by their ability to maintain glucose homeostasis. Two other striking characteristics of these RipCrePten flox/flox mice were that they were significantly smaller than controls and had a shorter lifespan. The authors suggested that these two features might be due to the deletion of Pten in the hypothalamus of the embryonic brain (Stiles et al., 2006) .
The RipCrePten flox/flox mice of Nguyen et al. (2006) displayed a very similar phenotype, being small in size and showing an increase in islet cell mass that was attributable to elevations in the number and cell size of b-cells. Again, the mutant mice showed lower fasting blood glucose and decreased blood insulin levels. In a glucose tolerance test, these mutants showed only a modest elevation in blood glucose and a faster return to glucose baseline levels than did wild-type mice. Furthermore, a significant fraction of the mutant mice displayed severe hypoglycemia and seizure activity and died prematurely (before the age of 5 weeks). To identify a reason for the decreased body size of the mutant mice, Nguyen et al. analysed mRNA levels of growthhormone-releasing hormone, IGF-1 and IGF-1 receptor but did not detect any significant differences between wild-type and mutant mice. As observed by Stiles et al. as well, b-cells from the mutant mice generated by Nguyen et al. were protected from apoptosis induced by multiple low-dose streptozotocin treatment and the animals did not develop diabetes. Neither strain of RipCre mice developed pancreatic tumors.
To study the importance of Pten in pancreatic tumorigenesis, Stanger et al. (2005) deleted Pten in the pancreas using Cre recombinase expression driven by the Pdx1 gene promoter, which is active during pancreatic development. Stanger et al. showed that Pdx1CrePten flox/flox mice lacked Pten protein expression in all pancreatic cells, including islet, ductal and centroacinar cells. Glucose homeostasis was not dysregulated in these mutants as judged by fed and fasting blood glucose levels and glucose tolerance test. However, the Pten-deficient b-cells were enlarged and irregularly shaped. The number of centroacinar cells was increased in the mutant mice and these cells exhibited increased BrdU-labeling. At 3 weeks of age, ductal metaplasia of the acini was observed, suggesting an active metaplastic transition from centroacinar cells to ductal cells. At 8-12 weeks of age, the mutant mice showed wasting and respiratory distress, and frequently died before the age of 6 months. Histologically, there were cystic changes in mutant pancreata with mucinous metaplasia of the epithelial cells. Out of 14 mice, two showed malignant transformation of these lesions. Stanger et al. then crossed their Pdx1CrePten flox/flox mice into a p53 À/À background and noted a significant increase in pancreatic tumor formation, with 3 out of 5 double-mutant mice developing cancers. These data suggest that Pten may play a role in the development of murine pancreatic tumors.
The data presented above indicate that Pten inactivation in the pancreas results in increased insulin sensitivity and hypoglycemia and may result in cystic changes of this organ due to mucinous metaplasia. Thus, Pten is important for the physiological function of the pancreas as well as for the conservation of normal organ structure. With respect to tumor suppression, it seems that loss of Pten alone has not a strong impact on pancreatic tumorigenesis, at least in mice. However, in the absence of another tumor suppressor, such as p53, loss of Pten increases the frequency tumor formation. Plum et al. (2006) generated mice in which Pten was selectively deleted in the hypothalamic neurons that express Pomc. The mutant mice displayed hyperphagia and developed obesity. In male mice, this increase in body weight was associated with increased consumption of a normal diet. Females maintained normal body Roles of PTEN: a tissue-by-tissue survey CB Knobbe et al weight on a normal diet but became obese on a high-fat diet. Interestingly, male mutant mice were also longer than male wild-type mice, such that the mutant mice had similar body mass index values as the wild-type mice. The mutant mice were obese due to increased food intake rather than due to altered energy expenditure. Analysis of isolated Pomc-expressing neurons showed that, on average, the diameter of the Pomc perikarya was significantly greater in the absence of Pten. Moreover, the mutant neurons showed more efferent fibers than wild-type neurons, suggesting a more robust innervation of target areas of melanocortin action in mutant mice compared with wild type. However, the mutant neurons also displayed membrane hyperpolarization due to increased ATP-sensitive conductance of the K ATP channels. When this hyperpolarization was reversed by intraventricular administration of the K ATP channel blocker tolbutamide, the hyperphagic phenotype disappeared. In vitro data further showed that the increased conductance of the K ATP channels was dependent on the presence of phosphatidylinositol-3,4,5-trisphosphate, as treatment with the PI3K inhibitor LY294002 reversed the hyperpolarization phenotype. Taken together, these data show that Pten signaling in Pomc neurons is vital for the regulation of food uptake and, thus, body weight. (2005) deleted Pten in murine adipose tissue by placing Cre under the control of the fatty-acid-binding protein promoter (aP2Cre). Inactivation of Pten in adipocytes neither resulted in gross morphological changes to the adipose tissue nor affected the adipose tissue mass. However, the authors observed a number of changes in the mutants, including increased systemic glucose tolerance and insulin sensitivity, and decreased fasting insulin and resistin levels. Resistin is a novel adipocyte hormone expression of which positively correlates with insulin resistance. Levels of other molecules influencing adipocyte function, such as leptin, adiponectin, tumor necrosis factor-a and interleukin-6, were not altered. Although little is known about resistin, it may act on the metabolism of hepatocytes, adipocytes and myocytes through regulation of AMP kinase activity (Kola et al., 2006) . These findings suggest that Pten plays a role in controlling serum insulin and resistin levels, which in turn regulate insulin sensitivity and AMP kinase activity in the liver. Interestingly, treatment of the mutant mice with streptozotocin did not result in the development of diabetes or hyperglycemia, suggesting that the insulin hypersensitivity of adipocyte-specific Pten-deficient mice allowed them to maintain proper glucose levels.
Hypothalamus
Adipocytes Kurlawalla-Martinez et al.
Skeletal muscle
To study the metabolic effects of Pten deletion in skeletal and heart muscle cells, Wijesekara et al. (2005) used the same approach as described below for deletion of Pten in cardiomyocytes, namely the expression of the Cre recombinase under the control of the muscle creatine kinase gene (MckCre). When fed a high-fat diet, the mutant mice were protected from insulin resistance, hyperinsulinemia and b-cell hypertrophy.
Mesenchymal cells
Humans with germline mutations of PTEN rarely present with overt endothelial, cardiac, smooth muscle or bone changes, with the exception of proteus-like syndrome.
Endothelial and endocardial cells
To characterize the importance of Pten for the development and physiology of endothelial and endocardial cells, Hamada et al. (2005) heterozygously inactivated Pten using a Tie2 promoter-driven Cre recombinase approach, resulting in selective inactivation of Pten in endothelial and endocardial cells but not in pericytes (PCs) or in vascular smooth muscle cells. As expected, mice heterozygous for this mutation (Tie2CrePten flox/ þ mice) did not show an overt phenotype. However, implantation of matrigel beads with or without impregnation of bFGF, bFGF þ Ang1 or bFGF þ VEGF resulted in a significantly greater vascular infiltration into the beads in Tie2CrePten þ /flox mice compared with Tie2CrePten
mice. Furthermore, tumor growth of subcutaneously transplanted tumor cells was promoted due to the enhanced angiogenesis in Tie2crePten flox/ þ mice compared with Tie2crePten þ / þ mice (Suzuki et al., 2007) . Homozygous conditional inactivation of Pten (Tie2-CrePten flox/flox ) in endothelial and endocardial cells resulted in embryonic lethality by E11.5. However, normal Mendelian frequency was maintained until E9.5, indicating that Pten is dispensable for early embryonic development of endothelial and endocardial cells. Tie2CrePten flox/flox embryos did not show gross anatomical abnormalities until E8.25, and E9.5 mutants exhibited increased numbers of capillaries that were comprised of oversized endothelial cells. The death of Tie2CrePten flox/flox embryos was attributed to pericardial cavity enlargement, and leakage of blood into the pericardial cavity and around large trunk vessels caused by impaired recruitment of pericytes and vascular smooth muscle cells to blood vessels, and of cardiomyocytes to the endocardium (Hamada et al., 2005; Suzuki et al., 2007) .
These data indicate that Pten is critically required for the control of normal development of the vascular system. Furthermore, these data imply that Cowden disease patients may not only be at risk of developing tumors due to the lack of Pten tumor suppressor function in the tissue cells themselves, but may also experience very rapid growth of these tumors due to the effects of PTEN loss on tumor angiogenesis. Crackower et al. (2002) used MckCre to conditionally inactivate Pten in murine cardiac myocytes. The mutant mice showed cardiac hypertrophy (especially of the left ventricle) and decreased cardiac contractility.
Cardiac myocytes
The cardiac hypertrophy was present in 10-week-old mice and did not increase over time. Histologically, the architecture of the heart muscle showed no evidence of disruption by increased fibrotic tissue or adipocytes but the size of individual cardiomyocytes was increased. Physiologically, the heart showed decreased contractility. By generating MckCrePten flox/flox
PI3Kg
À/À mice, Crackower et al. demonstrated that the phenotype of reduced contractility (but not hypertrophy) could be reversed by the deletion of PI3Kg. On the other hand, MckCrePten flox/flox PIK3a DN/DN mice showed a reversal of cardiac hypertrophy but not of reduced contractility. These data imply that PI3Ka is important for cardiac hypertrophy, whereas PI3Kg is important for cardiac contractility. In a follow-up study, Oudit et al. (2008) showed that deletion of Pten in cardiomyocytes protected the heart from maladaptive remodeling upon biomechanical stress.
As maladaptive remodeling has been linked to heart failure in humans, the presented data may be of interest for future clinical trials.
Smooth muscle
To analyse the impact of inactivation of Pten in smooth muscle cells, the progenitors of which are thought to be involved in the development of leiomyosarcomas, Hernando et al. (2007) crossed Pten flox/flox mice with TaglnCre mice. TaglnCre mice express Cre under the control of the smooth muscle-22-a promoter. The resulting mutants showed a decrease in body size compared with their wild-type littermates and developed leiomyosarcomas at a very high rate (B80%). The tumors appeared early in life, resulting in a median lifespan of approximately 70 days.
Bone and cartilage
To study Pten function during murine bone and cartilage development, Ford-Hutchinson et al. conditionally deleted Pten in osteo-chondroprogenitor cells using Cre driven by the Col2a1 promoter. Analysis of the mutant mice revealed growth plate dysfunction and overgrowth (especially of the vertebrae), which resulted in longer mice. Although increased pAkt and pS6 activities were detected in bone and cartilage cells, no increase in proliferation was observed. Rather, the bones showed increased matrix deposition with an overall increase in size as well as accelerated hypertrophic differentiation. After monitoring for 12 months, tumorigenesis in the form of metastatic osteosarcomas was observed in only 2 out of 12 mice. No chondrosarcomas, hamartomatous lesions and/or benign tumors were detected.
In a second study, the specific deletion of Pten in osteoblasts was achieved using Cre under the control of the osteocalcin promoter (OcCre) (Zhang et al., 2002) . The resulting mutants developed normally but bone volume and density increased with advancing age (Liu et al., 2007) . Pten-deficient osteoblasts were less susceptible to apoptosis and showed accelerated differentiation. The increase in bone mass could be induced by the loss of a single Pten allele and was due to elevated bone formation and mineral apposition rates. Bone resorption was not defective, as the number of osteoclasts increased coordinately with the number of osteoblasts (Liu et al., 2007) .
These studies have shown that the deletion of Pten in bone-and cartilage-producing cells results in overgrowth of the skeletal system. Taken together, Pten is important for normal bone turnover and influences tumor development.
Discussion
Now, there is no doubt that PTEN is one of the major tumor suppressor genes in mammals. In humans, PTEN has been studied extensively in primary tumors, and the different modes of PTEN inactivation in various malignancies are being elucidated. Researchers are also looking at the consequences of PTEN inactivation for prognosis, treatment and overall survival of cancer patients. Clinical observations are greatly supported by work done in numerous mouse models of Pten deficiency. The first Pten knockout strains created by Di Cristofano et al. (1998) , Suzuki et al. (1998) and Podsypanina et al. (1999) galvanized the field. Although homozygous Pten inactivation turned out to be embryonically lethal, heterozygous Pten inactivation resulted in the development of a diverse set of tumors with high penetrance and early onset, including lymphomas, breast and endometrial hyperplasia and cancers, and malignancies of the prostate and adrenal glands. One of the most exciting facts of these heterozygous mouse models is how well they recapitulate the human disease phenotype associated with human germline PTEN mutations, such as in Cowden disease. However, analyses of the importance of Pten for the homeostasis of other tissues and organ systems could not be performed using mice bearing the null Pten allele. This hurdle led to the development of a plethora of mouse strains created by tissue-specific conditional deletion of Pten (Table 1) . The brain was the first tissue to be targeted due to the high frequency of PTEN mutations in human glioblastomas. Using a NesCre transgenic mouse strain, Groszer et al. (2001) deleted Pten in neural stem cells, resulting in the deletion of Pten throughout the brain. Concurrently, Backman et al. (2001) as well as Kwon et al. (2001) used GfapCre mice to target Pten in a subset of cells within the brain. The latter studies yielded the interesting, and at that time unexpected, finding that the usage of GfapCre led to Pten deletion mostly restricted to neuronal cells in the cerebellum and hippocampus, as opposed to widespread deletion in astrocytes. However, this distribution pattern of Pten loss resulted in a mouse phenotype recapitulating human Lhermitte-Duclos disease, a condition associated with germline PTEN mutations. Further analyses of these mice as well as of NseCrePten mutant mice revealed even more extensive similarities to the human conditions associated with germline mutations, such as seizures and aspects of autism. Since 2001, Pten has been specifically deleted in numerous organs and tissues, and both expected and unexpected phenotypes have been documented. The bulk of the evidence points toward the involvement of Pten not only in protection from tumorigenesis but also in normal development and physiology of various organ systems. For example, Pten is strongly involved in the regulation of metabolism, particularly in insulin and glucose homeostasis. Studies of mice in which Pten was deleted specifically in hepatocytes, b-cells or the hypothalamus show increased insulin responsiveness and decreased blood glucose levels (Horie et al., 2004; Stiles et al., 2004 Stiles et al., , 2006 Kurlawalla-Martinez et al., 2005; Nguyen et al., 2006; Plum et al., 2006) . Another interesting Pten function, which is only starting to be elucidated now, is the apparent role Pten plays in protecting stem cells from premature cell cycle entry and preventing detrimental depletion of the stem cell pool. This phenomenon has been best demonstrated for hematopoietic stem cells (Yilmaz et al., 2006; Zhang et al., 2006) and oocytes (Reddy et al., 2008) .
From all these studies, it has become evident how important proper Pten signaling is not only to protect against tumor formation but also to regulate a vast array of physiological and pathological phenomena. The strong correlations observed between findings in human diseases and syndromes and the phenotypes of the different mutant mouse strains underline the importance of these mouse models. Furthermore, because of these similarities, they may provide us with greater understanding of Pten and PI3K pathway regulation not only in mice but also in humans, and may be of great value to study ways to specifically modify various pathological conditions in humans as well as for testing of novel hypotheses and experimental therapies. 
